Anticholinergics linked to increased risk of dementia

Anticholinergics linked to increased risk of dementia

April 30 2018 Anticholinergic drugs used in helping control some involuntary muscle movement...

Women of childbearing potential must be on Pregnancy Prevention Programme if taking valproate

Women of childbearing potential must be on Pregnancy Prevention Programme if taking valproate

April 26 2018 Women and girls of childbearing potential must no longer take valproate medicines...

Buprenorphine may be safer than methadone in opioid substitute therapy, study suggests

Buprenorphine may be safer than methadone in opioid substitute therapy, study suggests

April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone...

Class of diabetes drug linked to increased risk of irritable bowel disease

Class of diabetes drug linked to increased risk of irritable bowel disease

March 29 2018 A study has shown that dipeptidylpeptidase-4 inhibitors may increase the risk of...

Cochrane review indicates mefloquine is safe in pregnancy, but adverse effects are a barrier to use

Cochrane review indicates mefloquine is safe in pregnancy, but adverse effects are a barrier to use

March 29 2018 Mefloquine is safe to use for malaria prevention during pregnancy, a Cochrane...

  • Anticholinergics linked to increased risk of dementia

    Anticholinergics linked to increased risk of dementia

    Monday, 30 April 2018 12:08
  • Women of childbearing potential must be on Pregnancy Prevention Programme if taking valproate

    Women of childbearing potential must be on Pregnancy Prevention Programme if taking valproate

    Thursday, 26 April 2018 11:48
  • Buprenorphine may be safer than methadone in opioid substitute therapy, study suggests

    Buprenorphine may be safer than methadone in opioid substitute therapy, study suggests

    Monday, 23 April 2018 16:48
  • Class of diabetes drug linked to increased risk of irritable bowel disease

    Class of diabetes drug linked to increased risk of irritable bowel disease

    Thursday, 29 March 2018 11:27
  • Cochrane review indicates mefloquine is safe in pregnancy, but adverse effects are a barrier to use

    Cochrane review indicates mefloquine is safe in pregnancy, but adverse effects are a barrier to use

    Thursday, 29 March 2018 11:21

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

APPROVEDFebruary 17 2016

 

 

The latest medicines approved for use by the Scottish Medicines Consortium are:

  • guanfacine hydrochloride (Intuniv) - for treating ADHD in children and adolescents 6-17 years old where stimulants are not useful, as part of a comprehensive ADHD treatment programme;
  • golimumab (Simponi) - for treating adults with severe, active nr-axSpA (axial spondyloarthritis) in certain circumstances and where NSAIDs are not useful;
  • panobinostat (Farydak) - for use in combination with bortezomib and dexamethasone in adults with relapsed and/or refractory multiple myeloma who have received at least two prior regimens including bortezomib and an immunomodulatory agent;
  • ulipristal acetate (Esmya) - for the intermittent treatment of moderate to severe symptoms of uterine fibroids in women of reproductive age;
  • fulvestrant (Faslodex) - for treating post-menopausal women with oestrogen receptor positive, locally advanced or metastatic breast cancer for disease relapse on or after adjuvant anti-oestrogen therapy, or disease progression on therapy with an anti-oestrogen.

In addition, the SMC has not recommended eculizumab (Soliris) for the treatment of adults and children with atypical haemolytic uraemic syndrome (aHUS)

Links:

SMC announcement

SMC February Briefing Note

Clinical News

May 24 2018 Dementia patients are being helped to rekindle memories with a multi-sensory ‘memory box’ containing items and scents of the high street chemist.
May 24 2018 Dementia patients are being helped to rekindle memories with a multi-sensory ‘memory box’ containing items and scents of the high street chemist. Boots has helped develop the box with...